by MM360 Staff | Jan 27, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jan 27, 2026 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by Marisa Wexler, MS | Jan 26, 2026 | Myeloma News
The U.S. Food and Drug Administration (FDA) has granted breakthrough designation to soficabtagene geleucel (sofi-cel), a cell therapy designed to treat relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma (T-ALL/LBL), blood...
by MM360 Staff | Jan 24, 2026 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by Marisa Wexler, MS | Jan 23, 2026 | Myeloma News
After a year of treatment with the experimental medication atebimetinib as an add-on to chemotherapy, about two-thirds of pancreatic cancer patients in an ongoing study are still alive — nearly twice as many as would be expected to live this long with standard-of-care...
by MM360 Staff | Jan 23, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
